4E-BP1 expression in embryonic postmitotic neurons mitigates mTORC1-induced cortical malformations and behavioral seizure severity but does not prevent epilepsy in mice
- PMID: 37680968
- PMCID: PMC10480503
- DOI: 10.3389/fnins.2023.1257056
4E-BP1 expression in embryonic postmitotic neurons mitigates mTORC1-induced cortical malformations and behavioral seizure severity but does not prevent epilepsy in mice
Abstract
Hyperactivation of the mechanistic target of rapamycin complex 1 (mTORC1) pathway during neurodevelopment leads to focal cortical malformations associated with intractable seizures. Recent evidence suggests that dysregulated cap-dependent translation downstream of mTORC1 contributes to cytoarchitectural abnormalities and seizure activity. Here, we examined whether reducing cap-dependent translation by expressing a constitutively active form of the translational repressor, 4E-BP1, downstream of mTORC1 would prevent the development of cortical malformations and seizures. 4E-BP1CA was expressed embryonically either in radial glia (neural progenitor cells) that generate cortical layer 2/3 pyramidal neurons or in migrating neurons destined to layer 2/3 using a conditional expression system. In both conditions, 4E-BP1CA expression reduced mTORC1-induced neuronal hypertrophy and alleviated cortical mislamination, but a subset of ectopic neurons persisted in the deep layers and the white matter. Despite the above improvements, 4E-BP1CA expression in radial glia had no effects on seizure frequency and further exacerbated behavioral seizure severity associated with mTORC1 hyperactivation. In contrast, conditional 4E-BP1CA expression in migratory neurons mitigated the severity of behavioral seizures but the seizure frequency remained unchanged. These findings advise against targeting 4E-BPs by 4E-BP1CA expression during embryonic development for seizure prevention and suggest the presence of a development-dependent role for 4E-BPs in mTORC1-induced epilepsy.
Keywords: 4E-BP; cortical development; corticogenesis; epilepsy; mTOR; malformation of cortical development; seizures.
Copyright © 2023 Nguyen, Sharma and Bordey.
Conflict of interest statement
LN and AB are co-inventors on a patent application, PCT/US2020/054007 entitled “Targeting Cap-Dependent Translation to Reduce Seizures in mTOR disorders”. 2021-04-08: Publication of WO2021067752A1. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Expression of 4E-BP1 in juvenile mice alleviates mTOR-induced neuronal dysfunction and epilepsy.Brain. 2022 May 24;145(4):1310-1325. doi: 10.1093/brain/awab390. Brain. 2022. PMID: 34849602 Free PMC article.
-
4E-BP2-dependent translation in parvalbumin neurons controls epileptic seizure threshold.Proc Natl Acad Sci U S A. 2021 Apr 13;118(15):e2025522118. doi: 10.1073/pnas.2025522118. Proc Natl Acad Sci U S A. 2021. PMID: 33876772 Free PMC article.
-
Reappraisal to the study of 4E-BP1 as an mTOR substrate - A normative critique.Eur J Cell Biol. 2017 Jun;96(4):325-336. doi: 10.1016/j.ejcb.2017.03.013. Epub 2017 Apr 8. Eur J Cell Biol. 2017. PMID: 28427795 Review.
-
Normalizing translation through 4E-BP prevents mTOR-driven cortical mislamination and ameliorates aberrant neuron integration.Proc Natl Acad Sci U S A. 2016 Oct 4;113(40):11330-11335. doi: 10.1073/pnas.1605740113. Epub 2016 Sep 19. Proc Natl Acad Sci U S A. 2016. PMID: 27647922 Free PMC article.
-
4E-BP1, a multifactor regulated multifunctional protein.Cell Cycle. 2016;15(6):781-6. doi: 10.1080/15384101.2016.1151581. Cell Cycle. 2016. PMID: 26901143 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources
Miscellaneous